Dallah Healthcare Company (4004.SE)

Also known as:  DHC, Dallah Health
Data delayed by 15 minutes
44.70 SAR 0.400.90%
As of 21 MAY 2020 10:17 GMT|Saudi SE

DHC Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
24.44
Upside
-
Target Price (Mean)
-
52Wk
41.7 16 MAR
52.7 05 MAR

Open
44.45 SAR
Previous Close
44.70 SAR
Turnover
13.80M SAR
EPS
2.032 SAR
Volume
310,437
Transactions
654
Market Cap
3.19B SAR
IPO Date
16-Dec-2012
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Dallah Healthcare CompanyLast updated on: 30 April 2020

Business Summary
Ownership and operation of general hospitals. Through its main subsidiaries, manufacture of branded drugs; distribution of pharmaceuticals; offers hospital and medical center maintenance services.
Country of Incorporation
Ownership Type
Established In
1994
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
4004.SSEOrdinarySARSaudi SE4004

Contact details

Primary address
Al Nakheel Tower
King Fahad Road 1157
2nd Floor
Al Nakheel Area
87833
Saudi Arabia
Riyadh
12381
CONTACT
  • Tel: +966 11-299-5555
  • Tel: +966 11-225-5065
  • Tel: +966 11-225-5769
  • Fax: +966 11-470-2748
  • Fax: +966 11-225-0602
  • Fax: +966 11-455-0803
  • Email: www.dallahhealth.com
Region
Riyadh
All Related News
All Press Releases

Food in plenty for all in the UAE

UAE's well thought-out strategy has guaranteed availability of food and medical products in the local markets

Khaleej Times - Monday 25 May 2020
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Ahmad Bin Saleh Mohammed Babaeer
Chief Executive Officer and Managing Director
Mr Khalid Mohammed Ali Al Saudi
Chief Financial Officer
Dr Salah Rashed Al Faqih
Chief of Medical Staff

Board Members

Mr Tariq Othman Abdullah Al Qusabi
Chairman
Mr Mohieddine Saleh Abdullah Kamel
Vice Chairman
Dr Mohammed Rashed Mohammed Al Fagih
Director
All People

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
MOUWASAT MED SEV84.600 SAR2.17
PHARMACEUTICALS27.300 SAR1.87
SAUDI GERMAN HSP25.500 SAR-0.58
AL HAMMADI CO20.000 SAR0.00
SULAIMAN ALHABIB62.700 SAR-2.03
All Peers
Morning Briefing

Monday Outlook: Dollar holds advantage on Hong Kong tensions, oil drops

Monday Outlook: Dollar holds advantage on Hong Kong tensions, oil drops

Global markets extend losses amid souring relations between China and the United States

Read More

Most Viewed Stocks

Stock Market Data

Powered By Knowledge Direct

Stock Screener

All Stocks